35 results about "Blood viscosity" patented technology

The invention discloses a medicine formula for preventing cerebral infarction and promoting rehabilitation and a preparation method thereof, and belongs to the technical field of preparation of medicines for preventing cerebral infarction, the medicine formula comprises the following raw materials by weight: 10-15 parts of flatstem milkvetch seed, 10-15 parts of dodder, 10-15 parts of tortoise plastron, 10-12 parts of red peony root, 6-9 parts of safflower, and 15-30 parts of red sage root. According to the invention, the flatstem milkvetch seed, the semen cuscutae and the tortoise plastron are used for nourishing liver and kidney, replenishing essence and benefiting marrow, so that the traditional Chinese medicine theory that kidney dominates bone marrow generation and brain is marrow sea is met, and brain function decline is improved from the source; meanwhile, the radix salviae miltiorrhizae, the radix paeoniae rubra and the flos carthami have the effects of promoting blood circulation to remove blood stasis, activating meridians to stop pain, effectively improving brain microcirculation, inhibiting platelet aggregation and reducing blood viscosity, and supplement each other to achieve the effects of strengthening the body resistance to eliminate pathogenic factors and treating both symptoms and root causes, so that the traditional Chinese medicine composition can be used for preventing cerebral infarction of high-risk groups and is also suitable for functional recovery in the rehabilitation period after cerebral infarction.

State of art techniques for measurement of blood viscosity, RBC concentration and the like are in vitro methods. Embodiments of the present disclosure provide a method and system for in vivo non-invasive measurement of blood parameters using Laser Enabled Swept Frequency Acoustic Interferometry (LE-SFAI) principle. A Continuous Wave Laser diode based Photo Acoustic (CWPA) signal in frequency domain generated from laser excitation incident on a biological tissue of a subject carrying blood vessel is acquired by the ultrasound sensor and converted to a windowed time domain CWPA signal limited to two peaks. The signal characteristics such as risetime, amplitude, and time difference between first peak and the second peak are obtained to derive blood viscosity, Red Blood Corpuscles (RBC) concentration, and blood vessel diameter.

The invention discloses a traditional Chinese medicine composition and a traditional Chinese medicine preparation for treating sleep disorder caused by new coronavirus infection and a preparation method thereof, and belongs to the technical field of traditional Chinese medicines. Aiming at the problems that no medicine with definite curative effect exists for sleep disorder of a new coronavirus infected patient at present, and the medicine can only depend on the individual immunity of the patient to resist, the traditional Chinese medicine composition comprises the following traditional Chinese medicinal materials in parts by weight: 10g of radix pseudostellariae, 12g of radix paeoniae rubra, 10g of radix salviae miltiorrhizae, 6g of rhodiola rosea, 6g of exocarpium citri grandis, 5g of ginger processed pinellia, 15g of poria cocos, 15g of poria with hostwood, 15g of herba patriniae, 15g of tuber fleeceflower stem, 12g of hairyvein agrimony, 6g of liquorice, 10g of chrysanthemum and 6g of cassia twig. The traditional Chinese medicine composition is based on the principles of tonifying qi and activating blood, reducing phlegm and dredging collaterals, and clearing pestilence and soothing nerves, all the medicines are synergistic and supplement one another, the blood oxygen concentration and the red blood cell oxygen carrying capacity of a human body are improved, the blood viscosity is reduced, microcirculation is promoted, residual toxins are eliminated, and patients are helped to recover high-quality sleep.

The application provides a blood viscosity detection method, device and equipment. The blood viscosity detection method comprises the following steps: inputting a replacement fluid to a vein pipeline through a hard pipeline at a first flow rate, and determining a first inlet and outlet pressure difference of the hard pipeline; determining the viscosity of the replacement fluid according to the pipeline attribute of the hard pipeline, the first flow rate and the first inlet and outlet pressure difference; if the difference between the viscosity of the replacement fluid and the viscosity of water is within a first preset range, then determining a viscosity coefficient according to the viscosity of water, the first flow rate and the first inlet and outlet pressure difference; performing dialysis on blood, and determining the second flow rate of the blood in the hard pipeline after dialysis and the second inlet and outlet pressure difference of the hard pipeline in real time; and determining the real-time viscosity of the blood during dialysis according to the viscosity coefficient, the second flow rate and the second inlet and outlet pressure difference. The application solves the problem that the blood viscosity cannot be detected during hemodialysis treatment in the prior art.

The invention discloses a single-stage negative oxygen ion flow device for purifying blood cells, which belongs to the technical field of electrotherapy, negative ion therapy and blood purification, and comprises a single-stage negative oxygen ion generation and targeted guide and grounding loop. According to the device, a high-purity negative oxygen ion flow with the particle size smaller than 0.01 mu m is generated through a single-stage negative high voltage and double shielding technology and enters a human body through skin / respiratory tract double paths, a device-human body-ground closed charge circulation loop is constructed, deep purification of blood cells is achieved through quadruple mechanisms such as cell membrane potential repair, and the purpose of purifying the blood cells is achieved. The device is suitable for household blood health care and auxiliary treatment of hyperviscosity and microcirculation disturbance of medical institutions, solves the problems of low ion purity, poor penetrability, target deficiency and the like of traditional equipment, and is high in safety and remarkable in purification effect.

A blood-clearing and lipid-lowering pill is composed of the following ingredients in the indicated weight ratios: Astragalus membranaceus 54-74, Salvia miltiorrhiza 54-74, Paeonia lactiflora 54-74, Carthamus tinctorius 33-53, Pheretima aspergillum 54-74, Hirudo medicinalis 33-53, Crataegus pinnatifida 54-74, Polygonum multiflorum 54-74, Cassia tora 54-74, Gastrodia elata 33-53, Uncaria rhynchophylla 54-74, Eucommia ulmoides 33-53, Achyranthes bidentata 54-74, Os draconis 54-74, Ostrea gigas 54-74, Prunella vulgaris 54-74, and Alisma plantago-aquatica 54-74. This invention can reduce blood viscosity to normal levels in a short period, allowing some patients with vascular stenosis exceeding 75% who require stents to avoid stent grafting, and enabling stroke patients to gradually recover their function.

The external application medicine bag is prepared from the following raw materials in parts by weight: 6 to 8g of flos carthami, 5 to 7g of ground beetles, 7 to 9g of leeches, 5 to 6g of akebia stems, 8 to 10g of herba taxilli, 6 to 8g of gadflies, 5 to 7g of sappan wood, 8 to 10g of radix salviae miltiorrhizae, 6 to 9g of radix paeoniae rubra, 5 to 7g of native copper, 7 to 9g of catechu, 8 to 10g of fossil fragments, 6 to 8g of oysters and 7 to 9g of rhizoma gastrodiae. The traditional Chinese medicine bag has the beneficial effects that the traditional Chinese medicine bag has comprehensive conditioning effects of dredging meridians and collaterals, removing stasis and blocking and reducing blood viscosity, can effectively prevent cardiovascular and cerebrovascular diseases through long-term local external application according to a treatment course, and has an auxiliary treatment effect on various common diseases such as hypertension, insomnia, anxiety, cerebral infarction and lumbar disc herniation; it is worth mentioning that by means of the three-dimensional structural design of the paper folding tea bag, the dissolution efficiency of effective components is remarkably improved, meanwhile, the packaging size is reduced by 60%, and the tea bag is more environmentally friendly and portable; meanwhile, through a standardized preparation process, the use convenience and safety can be taken into account on the basis of ensuring stable release of the drug effect.

The application belongs to the field of blood viscosity monitoring, and provides a resonance-based non-invasive blood viscosity monitoring method and system. The method comprises determining corresponding resonance frequency and resonance incidence angle; the signal wave of the resonance frequency is incident to the target blood vessel region of the current individual at the resonance incidence angle each time the measurement is performed, and the signal wave characteristic parameter at each time of measurement is extracted; the signal wave characteristic parameter comprises the propagation speed of the signal wave in the blood, the attenuation rate of the signal wave, the change of the phase of the signal wave, and the reflection intensity of the signal wave; the change direction of the blood viscosity in single detection is inferred according to the change of the propagation speed of the signal wave in the blood in the single detection process; and the blood viscosity value in single detection is obtained based on all the signal wave characteristic parameters in the single detection process and the relationship model of the signal wave characteristic parameters and the blood viscosity which is constructed in advance.

The utility model relates to medical equipment technical field discloses a kind of platelet-rich plasma separators, comprising: round plate, the outer surface of the round plate is fixedly installed with limit block.This kind of platelet-rich plasma separator, due to the design of movement mechanism, reach the flexible adjustment effect of centrifugal radius without replacing centrifugal cup, can be according to different patient blood viscosity, hematocrit and other indexes, accurately control centrifugal force, avoid platelet residue or excessive activation, significantly improve platelet-rich plasma preparation quality and biological activity.Discard the cumbersome operation of traditional replacement centrifugal cup, substantially improve operation efficiency, while reducing the mismatch risk caused by frequent replacement of spare parts, reduce the operation burden of medical staff, reduce equipment spare parts procurement cost and management difficulty, effectively improve the versatility and utilization of equipment, reduce hospital equipment procurement and maintenance cost.

1. The name of the design product: semiconductor laser therapeutic instrument. 2. The use of the design product: for wearing on the wrist, by irradiating the acupoint (radial artery), to achieve the purpose of preventing and treating diseases such as improving blood rheological properties and reducing blood viscosity. 3. The design points of the design product: in shape. 4. The picture or photo that best indicates the design points: perspective view 1.

The invention discloses a special diet for improving cardiovascular and cerebrovascular diseases and microcirculation disturbance and a preparation method thereof. The health food is prepared from the following raw materials in parts by weight: 30-35 parts of Chinese yam peptide, 30-35 parts of earthworm protein peptide, 20-25 parts of freeze-dried natto powder, 15-20 parts of euphausia superba oil microcapsule powder, 10-15 parts of red yeast rice powder, 5-10 parts of taurine, 5-10 parts of ginseng, 2-5 parts of vitamin C, 2-5 parts of vitamin B1 and 2-5 parts of vitamin B2. The Chinese yam peptide, the earthworm protein peptide, the natto freeze-dried powder, the euphausia superba oil micro-capsule powder, the red yeast rice powder, the taurine, the ginseng, the vitamin C, the vitamin B1 and the vitamin B2 are prepared into the special diet for improving cardiovascular and cerebrovascular diseases and microcirculation disturbance, and various natural plants are matched with active effective components of medicinal and edible foods, so that the special diet has the effects of being medicinal and edible and being free of toxic and side effects. Meanwhile, the nutrition intervention effect is achieved on serious diseases such as cardia-cerebrovascular diseases and the like; the traditional Chinese medicine composition can restore original vitality of heart and cerebral vessels, improve blood and oxygen supply functions of whole body tissues, and reduce blood fat and blood viscosity.

This invention belongs to the field of traditional Chinese medicine (TCM) technology, specifically relating to a TCM composition with detoxifying and uterus-warming effects and its application in the preparation of external products. The medicinal component of this external TCM product is composed of fenugreek, amethyst, rose, pomegranate seed, centella asiatica, long pepper, five-finger peach, lycopodium, litchi seed, and achyranthes bidentata. Animal experiments show that this product can significantly reduce the number of writhing movements in animals with cold-induced blood stasis type dysmenorrhea, lower COX-2 and PGE2 levels in the uterus, and improve peritoneal inflammation, demonstrating good detoxifying, blood stasis-removing, menstruation-regulating, and pain-relieving effects. Regarding blood rheology, it exhibits the effects of inhibiting platelet aggregation, dilating blood vessels, reducing blood viscosity, and balancing TXA2 and PGI2 levels, reflecting its effects of warming the kidneys and uterus, and strengthening the body's foundation. In summary, the TCM composition of this invention and its prepared external product can warm the kidneys and uterus, promote diuresis and eliminate turbidity, providing a novel TCM external application solution for the clinical treatment of cold-induced blood stasis type dysmenorrhea.

The present application relates to yellow rice wine preparation technical field, especially to a kind of mixed grain health-care yellow rice wine and preparation method thereof.The present application provides a kind of mixed grain health-care yellow rice wine, which is prepared from the following components by mass fraction: waxy millet 40-60 parts, waxy rice 30-40 parts, waxy millet 20-30 parts, waxy sorghum 13-17 parts, Chinese medicine compound 10-14 parts and fermentation inoculum 10-14 parts;The yellow rice prepared by the present application has bright color, refreshing taste, pure and elegant wine quality, unique flavor, and is rich in nutritional elements and Chinese medicine fermentation, which can promote blood circulation, promote tissue metabolism and enhance cell vitality.Long-term drinking not only has good health effect, but also can beautify and nourish skin.

The application discloses a non-invasive real-time evaluation method and system for blood fluidity and a wearable device, and belongs to the technical field of biomedical signal processing and intelligent health monitoring. The method comprises the following steps: acquiring an event timestamp of a blood blocking device and a physiological signal of a blood health measurement module; automatically intercepting a signal segment of a recovery stage based on the event timestamp; parallelly calculating a plurality of independent indexes characterizing the recovery process; performing validity checking on each index, and eliminating invalid or abnormal candidate values; and outputting a final recovery time after blocking by using a dynamic adaptive fusion strategy. The application further discloses a detection system and a wearable device for realizing the method. The application uses recovery kinetics after pressure relief to represent blood fluidity, realizes automatic and accurate detection of the recovery time through a multi-index cooperative judgment and a dynamic fusion mechanism, effectively suppresses noise interference and improves robustness, and can be used for non-invasive evaluation of vascular elasticity, blood viscosity and microcirculation function.

The provided is a torsional guided wave-based blood viscoelasticity measurement device and method using a capillary metal tube. The device includes a housing, a capillary metal tube, a signal receiving module, and a signal excitation module, where the capillary metal tube is disposed inside the housing and configured to hold a blood sample; the signal excitation module is disposed at one end of the capillary metal tube and includes a cuboid permanent magnet and an electrode; the signal receiving module is disposed at the other end of the capillary metal tube and includes a cylindrical permanent magnet and a receiving coil; an excitation is performed on the capillary metal tube to generate a torsional guided wave; when a fluid viscosity in the tube changes, energy attenuation of the guided wave propagating along the tube differs; and the guided wave energy attenuation is defined to reflect a relative blood viscosity.

The invention discloses a micro-metal tube thrombus elasticity detection device and method based on an L(0,1) longitudinal mode guided wave. The device includes a device housing, a temperature control module, a micro-metal tube, and a magnetostrictive assembly. The housing is externally connected to the temperature control module to realize internal constant temperature, the replaceable micro-metal tube is installed inside, the magnetostrictive assembly composed of a permanent magnet and a coil is provided at one end outside the tube. An L(0,1) longitudinal mode guided wave is excited on the micro-metal tube. When liquid viscosity within the tube changes, the energy attenuation of the guided wave propagating along the tube is different. The energy attenuation of the guided wave is defined through the attenuation rate of multiple echo peak values to reflect changes in the blood viscosity.

The invention provides an aggregation-induced emission type photosensitizer with a dihydrodibenzophenazine structure as well as a preparation method and application of the aggregation-induced emission type photosensitizer with the dihydrodibenzophenazine structure, and the aggregation-induced emission type photosensitizer with the dihydrodibenzophenazine structure is obtained by connecting an aggregation-induced emission element with multiple rotors to a framework of a vibration-induced emission dihydrodibenzophenazine derivative. The photosensitizer with the dihydrodibenzophenazine structure integrates the advantages of aggregation-induced emission and vibration-induced emission, and can be applied to fluorescence imaging of biological tissues; the photosensitizer with the dihydrodibenzophenazine structure has viscosity responsiveness and photosensitivity, so that the photosensitizer with the dihydrodibenzophenazine structure can be applied to blood viscosity detection, thrombus imaging and tumor light diagnosis and treatment, and particularly, the photosensitizer with the dihydrodibenzophenazine structure has good performance in blood viscosity detection, thrombus, particularly in-vivo imaging of cerebral thrombosis and tumor light diagnosis and treatment.

The application discloses a method for judging plaque stability before operation. The method reconstructs a carotid artery lesion stenosis model on the basis of collecting clinical data such as CTA and DSA of a head and neck of a patient; combines pathological data such as ultrasound, blood viscosity and blood fat to represent blood rheological property data of the patient, and constructs a multi-component and multi-phase flow model of the carotid artery of the human body; on the basis of testing the elastic properties of solid materials of stable plaques, unstable plaques and blood vessel walls, bidirectional fluid-structure coupling models containing the stable plaques and the unstable plaques are respectively constructed; numerical simulation is carried out on the above models, and the medical image examination data are compared and analyzed with the flow velocity, local cross-sectional flow and cross-sectional flow line of typical points in the two types of models to judge the stability of plaques in a lesion region of the patient. The application can provide visual changes of hemodynamic parameters of the patient for doctors by using numerical simulation, and provides a personalized medical examination scheme for carotid stenosis patients, and has great clinical significance.

The invention belongs to the technical field of medicine and health food, and particularly relates to a fish oil capsule for reducing blood viscosity and a preparation process. According to the invention, fish oil, curcumin and beta-cyclodextrin are compounded according to a specific ratio and play a synergistic role from different directions, so that the effect of effectively reducing blood viscosity is achieved. Wherein EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) in the fish oil can reduce triglyceride in blood, curcumin can reduce fibrinogen in the blood, and meanwhile, beta-cyclodextrin is matched to inhibit absorption of cholesterol by intestinal tracts, so that hemorheology indexes are adjusted in a multi-target manner, and blood circulation is improved. A double-layer capsule shell structure design is adopted, and the inner capsule shell is loaded with beta-cyclodextrin, so that the compatibility problem of other contents can be solved, and meanwhile, the release efficiency of the capsule in gastrointestinal tracts is promoted. The curcumin is subjected to phospholipidation treatment, so that the fat solubility and bioavailability of the curcumin can be remarkably improved, the curcumin is more easily compatible with a fish oil system, and a synergistic release effect is achieved in gastrointestinal tracts.

The invention provides a compound protein peptide composition and application thereof in improving health of heart and cerebral vessels, the compound protein peptide composition comprises earthworm protein peptide, collagen peptide, sea cucumber peptide and other active components, and a multi-target synergistic effect is achieved through a specific ratio and a preparation process. The composition can significantly enhance vascular elasticity, inhibit platelet aggregation and reduce blood viscosity, and is suitable for improving hypertension, hyperlipidemia and microcirculation disturbance. The product can be prepared into tablets, capsules or solid beverages, the uniformity of the tablets is guaranteed by adopting a three-dimensional mixing and segmented tabletting process, the activity of the capsules is maintained through nitrogen-filled sealing of an HPMC shell material, and the palatability of the solid beverages is improved by adding black tea powder and vitamin C. Animal experiments prove that systolic pressure is reduced by 35 mmHg, carotid artery blood flow is improved by 42%, the thrombus dissolution rate reaches 75%, and human body experiments show that the traditional Chinese medicine composition is safe and effective to cardiovascular and cerebrovascular sub-health people.

A wearable non-invasive blood viscosity monitor and methods of using the same are described. The blood viscosity monitor includes first and second sensors configured to sense blood parameters non-invasively from a subject and a processor circuit configured to generate an indication of blood viscosity using the sensed blood parameters from at least one of the first and second sensors and to generate a medical diagnostic using the indication of blood viscosity. An output circuit presents the medical diagnostic to alert a clinician about an elevated viscosity. The first and second sensors may be on the same or different fixation devices and adapted to provide measurements that are mixed and matched by the processor circuit to provide validation of measurements, averaging of measurements, or to select the most reliable data for each modality and measurement context.

The present application provides a traditional Chinese medicine composition for treating and / or preventing coronary heart disease, and a preparation method and application thereof. Specifically, the traditional Chinese medicine composition of the present application is prepared from raw materials comprising the following components: 8-13 parts of capillaris, 8-12 parts of atractylodes, 8-12 parts of alisma, 8-14 parts of curcuma, 10-20 parts of salvia, 8-14 parts of curcuma, 1-5 parts of panax notoginseng powder, 5-10 parts of rhizoma corydalis, 8-12 parts of pinellia, 5-10 parts of berberis, 4-10 parts of ginseng, 5-12 parts of dried tangerine or orange peel, and 4-10 parts of licorice. The present application also provides a method for preparing the traditional Chinese medicine composition of the present application and the use of the traditional Chinese medicine composition in preparing a medicine for treating and / or preventing coronary atherosclerotic heart disease. The traditional Chinese medicine composition of the present application can reduce blood viscosity, improve heart function, reduce myocardial infarction area, inhibit the formation of atherosclerotic plaques, regulate blood lipid levels, or reduce the level of myocardial injury markers in serum.

This invention discloses a concentrated tomato product that increases blood flow and its preparation method. On a dry basis, the product contains 3.0 g / 100g of cis-lycopene, 1.5 g / 100g of total phytosterols, and 0.8 g / 100g of total polyphenols. The phytosterols are composed of β-sitosterol and stigmasterol, and the polyphenols are composed of chlorogenic acid, caffeic acid, and ferulic acid. This invention maximizes the preservation of the tomato's nutritional components by screening high-lycopene tomato varieties and optimizing pretreatment, enzyme inactivation, and juicing process parameters. Simultaneously, by precisely adding exogenous phytosterols, polyphenol extracts, and synergistic components such as Omega-3 fatty acids and vitamin E, a multi-component synergistic system is constructed. The components work together synergistically to significantly enhance the product's function of increasing blood flow, effectively improving microcirculation, reducing blood viscosity, and providing protection for cardiovascular health.

The application provides a blood purification device and a storage medium. The pressure sensor of the blood purification device measures the liquid pressure of an elongated tube to obtain pressure measurement data. The storage medium stores program instructions executable by a processor. The processor can execute: outputting a replacement fluid to the elongated tube according to a preflush start instruction; calculating a replacement fluid pressure change amount and a replacement fluid pressure change time according to the pressure measurement data; determining a viscosity system parameter according to a preset viscosity of the replacement fluid, the replacement fluid pressure change amount and the replacement fluid pressure change time; performing dialysis on blood through a dialyzer according to a blood treatment instruction, and outputting the dialyzed blood to the elongated tube; calculating a first blood pressure change amount and a first blood pressure change time according to the pressure measurement data; and determining a first blood viscosity according to the viscosity system parameter, the first blood pressure change amount and the first blood pressure change time. The application solves the problem that blood viscosity cannot be detected during hemodialysis treatment.

The utility model discloses a laser light scattering device based on extracorporeal blood viscous flow condition simulation, which is characterized in that a liquid inlet of a first pulse pump is connected with a liquid outlet of a human body blood circulation model, a liquid outlet of the first pulse pump is connected with a liquid inlet pipe of a sample pipe, and a liquid outlet of the liquid inlet pipe of the sample pipe extends to one side of the bottom of an inner cavity of the sample pipe; a liquid outlet of the second pulse pump is connected with a liquid inlet of the human body blood circulation model, a liquid inlet of the second pulse pump is connected with a liquid outlet pipe of the sample pipe, and a liquid inlet of the liquid outlet pipe of the sample pipe extends to the other side of the bottom of the inner cavity of the sample pipe; the inner wall of the sample tube is coated with a layer of biological membrane for simulating vascular endothelial cells, and the sample tube can be horizontally fixed on a sample position of the laser light scatterometer; the pulse pump flow speed adjusting display screen is connected with the first pulse pump and the second pulse pump. By simulating the dynamic and static flowing conditions of human blood, the dynamic and static laser light scattering test of a flowing sample is realized, so that more accurate experimental data is obtained.

The application belongs to the field of blood glucose detection, and provides a non-invasive blood glucose measurement method, device, medium, product and equipment. The method comprises the following steps: extracting signal wave characteristic parameters of a resonance signal during the propagation in a blood vessel according to a predetermined resonance frequency and resonance incident angle of a current individual target blood vessel region; obtaining a blood viscosity value of single detection according to all signal wave characteristic parameters in a single detection process and a relationship model between the signal wave characteristic parameters and blood viscosity which is constructed in advance; and obtaining a corresponding blood glucose concentration value according to the blood viscosity value of single detection and a positive correlation model between the blood viscosity value of single detection and the blood glucose concentration which is constructed in advance.

To provide a composition that is unlikely to cause side effects such as discomfort, can prevent increases in blood viscosity, and has anti-inflammatory and analgesic effects.SOLUTION: The composition comprises: cat's claw and purple Ipe, and further comprises: glucosamine, ginger, and vitamin E. It contains 45-53 mass% of cat's claw, 20-28 mass% of purple Ipe, 10-16 mass% of glucosamine, 2-7 mass% of vitamin E, and 6-12 mass% of ginger to the total mass of cat's claw, purple Ipe, glucosamine, ginger, and vitamin E.SELECTED DRAWING: None

This invention provides a topical Chinese medicine preparation with the effects of promoting blood circulation, removing blood stasis, relieving pain, and analgesia, and its preparation method. It relates to the field of traditional Chinese medicine pharmaceutical technology. The preparation is made from *Xia Tian Wu*, *Jian Xue Fei*, *Qi Ye Lian*, *Shen Jin Cao*, *Wu Xiang Xue Teng*, *Jiu Long Pan*, *Jing Tian San Qi*, *Jiu Jie Cha*, *Ban Bian Qi*, *Huang Bai*, *Qing Hao*, and *Hei Gu Teng*. This invention's preparation has a reasonable combination of herbs and possesses the effects of promoting blood circulation, removing blood stasis, regulating qi and relieving pain, anti-inflammatory and analgesic properties, improving microcirculation, and regulating blood viscosity. It can significantly increase the pain threshold in mice and effectively relieve pain symptoms. Simultaneously, it can significantly improve microcirculatory disorders in the auricle of mice and increase the rate of change in microvascular diameter. Furthermore, this preparation can effectively improve lameness and mental state in rats with knee osteoarthritis combined with blood stasis, and can effectively improve the state of high blood viscosity, providing a new treatment option for painful diseases, microcirculatory disorders, and related conditions such as knee osteoarthritis caused by blood stasis.

The application belongs to the field of traditional Chinese medicines, and provides a preparation for treating or preventing diabetic foot and a preparation method thereof. The preparation contains Rhizoma polygonati, Caulis Spatholobi, Radix Angelicae Pubescentis, Notopterygium, Lumbricus, Hirudo, Asarum, Schizonepeta, Saposhnikovia divaricata, Carthamus tinctorius L., Cortex Moutan, Curcuma, Astragalus, and Kadsura. The traditional Chinese medicine composition promotes angiogenesis of diabetic foot, reduces blood viscosity, and promotes healing of ulcer wounds. The traditional Chinese medicine composition has a good therapeutic effect on treating diabetic foot. The traditional Chinese medicine composition has a simple preparation process, small side effects, and low recurrence rate.